NFATC1 and osteoarthritis: The present study demonstrated that CUR suppresses RANKL-induced osteoclastogenesis in vitro and alleviates DMM-induced osteoarthritis in mice via inhibiting NF-κB/JNK/NFATc1 signal pathway (Fig 9), which could serve as a strategy for the precise treatment of OA.